Open Access
Subscription Access
Open Access
Subscription Access
Detection of PVL gene for the presence of Leukocidin among Clinical Isolates of Staphylococcus aureus from Tertiary Care Hospital
Subscribe/Renew Journal
PVL and γ -haemolysin are considered to be members of a toxin family known as synergohymenotropic toxins, as they act on cell membranes by the synergy of two proteins that form a pore. Only 2% of S. aureus isolates produce PVL, while γ -haemolysin is produced by more than 99% of S. aureus isolates. PVL is the most leukocytolytic toxin in the family, however it does not exhibits no haemolytic activity on human erythrocytes. A sum of 20 clinical isolates of S. aureus were subjected to antibiotic sensitivity pattern followed by the detection of pvl gene by PCR. We have observed increased resistance to most of the routinely used antibiotics and 10% of our isolates found to have pvl gene. As this gene is directly associated with skin and soft tissue infections by S. aureus, our two isolates may even cause such infections, although none of these strains were not obtained from cutaneous lesions.
Keywords
Staphylcoccus Aures, Pvl Gene, PCR.
Subscription
Login to verify subscription
User
Font Size
Information
- Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998: 339; 520–532.
- Rogolsky M. Nonenteric toxins of Staphylococcus aurues. Microbiol Rev 1979: 43, 320–360.
- Dinges M, Orwin P, Schilievert P. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000: 13, 16–34.
- Pre´vost G, Criebier B, Couppie´ P et al. Panton–Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect Immun 1995: 63, 4121–4129.
- Kuroda M, Ohta T, Uchiyama I et al. Whole genome sequencing of methicillin-resistant Staphylococcus aureus. Lancet 2001: 357,1225–1240.
- Criebier B, Pre´vost G, Couppie´ P, Finck-Barbancon V, Grosshans E, Pie´mont Y. Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study. Dermatology 1992:185, 175–180.
- Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Tests, Approved Standards; Doucement M2-A9, 9th ed., Vol 26. Wayne, PA: CLSI, 2015
- Terry Alli OA, Ogbolu DO, Mustapha JO, Akinbami R, Ajayi AO. The non-association of Panton-Valentine leukocidin and mecA genes in the genome of Staphylococcus aureus from hospitals in South Western Nigeria. Indian Journal of Medical Microbiology, (2012): 30(2),159-64.
- Johnsson D, Molling P, Stralin K. Detection of Panton–Valentine leukocidin gene in Staphylococcus aureus by LightCycler PCR: clinical and epidemiological aspects. European Society of Clinical Microbiology and Infectious Diseases. 2004:10(10), 884-889.
- Finck-Barbancon V, Pre´vost G, Pie´mont Y. Improved purification of leukocidin from Staphylococcus aureus and toxin distribution among hospital strains. Res Microbiol 1991: 142, 75– 85.
- Lina G, Piemont Y, Godail-Gamot F et al. Involvement of Panton–Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999: 29, 1128–1132.
- Couppie´ P, Criebier B, Pre´vost G, Grosshans E, Pie´mont Y. Leukocidin from Staphylococcus aureus and cutaneous infections: an epidemiologic study. Arch Dermatol 1994:130, 1208–1209.
- Pre´vost G, Couppie´ P, Pre´vost P et al. Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol 1995: 42, 237–245.
Abstract Views: 146
PDF Views: 0